Skip to main content
Children's Hospital at Dartmouth Hitchcock (CHad)
In This Section

About Us

Norris Cotton Cancer Center's hemophilia program is one of three Federally Designated Comprehensive Hemophilia Treatment Centers in Northern New England.

This is especially relevant because a CDC study of 3,000 people with hemophilia showed that those who used a hemophilia treatment center were 40 percent less likely to die of a hemophilia-related complication compared to those who did not receive care at a treatment center. Similarly, people who used a treatment center were 40 percent less likely to be hospitalized for bleeding complications.

Our program meets the highest standards set by the National Hemophilia Foundation for a Comprehensive Hemophilia Center including an experienced team of adult and pediatric hematologists, clinical nurse specialists, adult and pediatric orthopedists, physical therapist, on site coagulation laboratory, infectious disease specialists, hepatologists, and a full range of anti-hemophilic factor products. Hemophilia centers throughout New England refer patients to DHMC for orthopedic surgery, radionuclide synovectomy, and diagnostic coagulation evaluation services.

The Public Health Service 340B Drug Pricing Program Program is a federal discount program available to HTCs and other covered entities. Our Hemophilia Program was the second hemophilia center in the nation to be an "approved covered entity" which enables patients to receive a significant cost reduction (estimated to be 15 to 20 percent) for certain product purchase from the Public Health Service (called "340B pricing"). For more information, see our brochure (PDF) describing the discount program.


The Cancer Center and Dartmouth-Hitchcock have the only onsite diagnostic coagulation lab within a 100 mile radius of Lebanon, and the only diagnostic coagulation clinic in NH. In 2007 we conducted 298 pediatric and adult new patient workups for congenital thrombosis and bleeding disorders. Clinic evaluations are held twice weekly.

Our program currently follows over 300 patients with inherited bleeding disorders. Patients live an average of 100 miles round trip from DHMC. Our Blood Bank is the only facility within a 100 mile radius to maintain a full complement of hemophilia products to manage any hemophilia problem or emergency.

We also provide an array of support services for hemophilia patients and their families.


Research interests of physicians and scientists at Norris Cotton Cancer Center include:

  • Innovative treatment approaches for bleeding and thrombosing disorders, and mechanisms and management of blood coagulation activation in malignancy
  • Control of cancer growth by the blood coagulation mechanism
  • Role of iron accumulation and age-related disease risk
  • Development of novel treatment protocols for rare bleeding disorders
Contact Us